I'm just going to come out and say it. Something is wrong here. J&J bought a private biotech company for 3.1 million and they are in a phase 1/2 clinical trial? For prostate cancer.
"Last week, Merck said it would pay $9.2 billion for Cidara Therapeutics, a 109% premium over the closing price the day before the deal, and Pfizer completed its acquisition of the obesity biotech Metsera only after beating a last-minute public effort by Novo Nordisk to spoil the agreement."
Approaching 2 years in UK for approval of GBM treatment. Not even applied to FDA or anywhere else.
These are THE Big Pharma companys. they know where future profits lie. They know where the science is headed.
Not one peep about NWBO? Not 1 offer that needs to go before shareholders. Nothing for a company that some declare the future SOC for all cancer tumors?
Sorry for the rant, but this is BS!
Right now I'm hoping for approval this year and 2$ a share. Then I'm out. I'm tired of the narrative all MMs and BP are against this company. Billions in naked shorts on "black pool" markets BS. This feels like mmat all over again.
oh, but volkswagon had a short squeeze and so did gamestop. It could happen here. BS!
Market Data 
Markets 
